NOT KNOWN FACTUAL STATEMENTS ABOUT AGO TUMOR

Hormonal therapy stays the treatment of initially choice for metastatic people with endocrine-responsive breast cancer (LoE 1a A, In the past ++). The sequential use of the readily available medicines is determined by the person pretreatment. Reassessment of ER, PR, and HER2 in tumor tissue at time of analysis of relapse is suggested Each time feas